Quantitative risk assessment for the induction of allergic contact dermatitis: Uncertainty factors for mucosal exposures

Contact Dermatitis

Volumn 49, Issue 3, 2003, Pages 140-147

  Farage, Miranda A ^a   Bjerke, Donald L ^b   Mahony, Catherine ^a   Blackburn, Karen L ^b   Gerberick, G Frank ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b Central Product Safety   (United States)

Author keywords

Allergic contact dermatitis; Buccal mucosa; Keratinization; Mucosa; No observable adverse effect level; Oral mucosa; Permeability; Quantitative risk assessment; Sensitization uncertainty factors; Vagina; Vulva

Indexed keywords

CHEEK MUCOSA; CONCENTRATION (PARAMETERS); CONTACT SENSITIZATION; EXPOSURE; KERATINIZATION; MEMBRANE PERMEABILITY; MOUTH HYGIENE; MOUTH MUCOSA; MUCOSA; NO OBSERVABLE ADVERSE EFFECT LEVEL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SAFETY; SKIN ALLERGY; UNCERTAINTY; VAGINA; VULVA;

ALLERGENS; BENCHMARKING; DATA INTERPRETATION, STATISTICAL; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; MOUTH MUCOSA; MUCOUS MEMBRANE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RISK ASSESSMENT; UNCERTAINTY; VULVA;

EID: 0347064079     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-1873.2003.00192.x     Document Type: Review

References (49)

1. Felter S P, Ryan C A, Basketter D A, Gilmour N J, Gerberick G F. Application of the risk assessment paradigm to the induction of allergic contact dermatitis. Regul Toxicol Pharmacol 2003: 37: 1-10.
2. Gerberick G F, Robinson M K, Felter S P, White I R, Basketter D A. Understanding fragrance allergy using an exposure-based risk assessment approach. Contact Dermatitis 2001: 45: 333-340.
3. USEPA (US Environmental Protection Agency). Glossary of IRIS terms. (available from: http://www.epa.gov/iris/ gloss8.htm#r) 2002.
4. Gerberick G F, Robinson M K, Ryan C A et al. Contact allergenic potency: correlation of human and local lymph node assay data. Am J Contact Dermat 2001: 12: 156-161.
5. Felter S P, Robinson M K, Basketter D A, Gerberick G F. A review of the scientific basis for uncertainty factors for use in quantitative risk assessment for the induction of allergic contact dermatitis. Contact Dermatitis 2002: 47: 257-266.
6. Edwards J N, Morris H B. Langerhans' cells and lymphocyte subsets in the female genital tract. Br J Obstet Gynaecol 1985: 92: 974-982.
7. Ahlfors E E, Larsson P A, Bergstresser P R. Langerhans' cell surface densities in rat oral mucosa and human buccal mucosa. J Oral Pathol 1985: 14: 390-397.
8. Patton D L, Thwin S S, Meier A, Hooton T M, Stapleton A E, Eschenbach D A. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol 2000: 183: 967-973.
9. Nauth H. Anatomy and physiology of the vulva. In: Vulvovaginitis, Elsner P, Marius J (eds): New York, NY, Marcel Decker, 1993, 1-18.
10. Sargeant P, Moate R, Harris J E, Morrison G D. Ultrastructural study of the epithelium of the normal human vulva. J Submicrosc Cytol Pathol 1996: 28: 161-170.
11. Thompson I O, van der Bijl P, van Wyk C W, van Eyk A D. A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. Arch Oral Biol 2001: 46: 1091-1098.
12. de Vries M E, Bodde H E, Verhoef J C, Junginger H E. Developments in buccal drug delivery. Crit Rev Ther Drug Carrier Syst 1991: 8: 271-303.
13. Elsner P, Wilhelm D, Maibach H I. Physiological skin surface water loss dynamics of human vulvar and forearm skin. Acta Derm Venereol 1990: 70: 141-144.
14. Elsner P, Maibach H I. The effect of prolonged drying on transepidermal water loss, capacitance and pH of human vulvar and forearm skin. Acta Derm Venereol 1990: 70: 105-109.
15. Britz M B, Maibach H I, Anjo D M. Human percutaneous penetration of hydrocortisone: the vulva. Arch Dermatol Res 1980: 267: 313-316.
16. Oriba H A, Bucks D A, MaibachH I. Percutaneous absorption of hydrocortisone and testosterone on the vulva and forearm: effect of the menopause and site. Br J Dermatol 1996: 134: 229-233.
17. van der Bijl P, Thompson I O, Squier C A. Comparative permeability of human vaginal and buccal mucosa to water. Eur J Oral Sci 1997: 105: 571-575.
18. van der Bijl P, van Eyk A D, Thompson I O. Penetration of human vaginal and buccal mucosa by 4.4-kd and 12-kd fluorescein-isothiocyanate-labeled dextrans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998: 85: 686-691.
19. van der Bijl P, van Eyk A D, Thompson I O. Permeation of 17beta-estradiol through human vaginal and buccal mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998: 85: 393-398.
20. van der Bijl P, van Eyk A D, Thompson I O, Stander I A. Diffusion rates of vasopressin through human vaginal and buccal mucosa. Eur J Oral Sci 1998: 106: 958-962.
21. Law S, Wertz P W, Swartzendruber D C, Squier C A. Regional variation in content, composition and organization of porcine epithelial barrier lipids revealed by thin-layer chromatography and transmission electron microscopy. Arch Oral Biol 1995: 40: 1085-1091.
22. Squier C A, Cox P, Wertz P W. Lipid content and water permeability of skin and oral mucosa. J Invest Dermatol 1991: 96: 123-126.
23. Lesch C A, Squier C A, Cruchley A, Williams D M, Speight P. The permeability of human oral mucosa and skin to water. J Dent Res 1989: 68: 1345-1349.
24. Squier C A, Hall B K. The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier. J Invest Dermatol 1985: 84: 176-179.
25. Squier C A. Penetration of nicotine and nitrosonornicotine across porcine oral mucosa. J Appl Toxicol 1986: 6: 123-128.
26. Britz M B, Maibach H I. Human labia majora skin: transepidermal water loss in vivo. Acta Derm Venereol Suppl (Stockh) 1979: 59: 23-25.
27. Elsner P, Wilhelm D, Maibach H I. Frictional properties of human forearm and vulvar skin: influence of age and correlation with transepidermal water loss and capacitance. Dermatologica 1990: 181: 88-91.
28. Potts R O, Guy R H. Predicting skin permeability. Pharm Res 1992: 9: 663-669.
29. Potts R O, Guy R H. The influence of molecular Volume and hydrogen-bonding on peptide transport across epithelial membranes. Pharm Res 1993: 10: 635-637.
30. Potts R O, Guy Rh. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm Res 1995: 12: 1628-1633.
31. Guy R H, Potts R O. Structure-permeability relationships in percutaneous penetration. J Pharm Sci 1992: 81: 603-604.
32. Conradi R A, Hilgers A R, Ho N F, Burton P S. The influence of peptide structure on transport across Caco-2 cells. Pharm Res 1991: 8: 1453-1460.
33. Conradi R A, Hilgers A R, Ho N F, Burton P S. The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability. Pharm Res 1992: 9: 435-439.
34. Britz M B, Maibach H I. Human cutaneous vulvar reactivity to irritants. Contact Dermatitis 1979: 5: 375-377.
35. Elsner P, Wilhelm D, Maibach H I. Sodium lauryl sulfate-induced irritant contact dermatitis in vulvar and forearm skin of premenopausal and postmenopausal women. J Am Acad Dermatol 1990: 23: 648-652.
36. Elsner P, Wilhelm D, Maibach H I. Irritant effect of a model surfactant on the human vulva and forearm. Age-related differences. J Reprod Med 1990: 35: 1035-1039.
37. Elsner P, Wilhelm D, Maibach H I. Effect of low-concentration sodium lauryl sulfate on human vulvar and forearm skin. Age-related differences. J Reprod Med 1991: 36: 77-81.
38. Kalia Y N, Pirot F, Potts R O, Guy R H. Ion mobility across human stratum corneum in vivo. J Pharm Sci 1998: 87: 1508-1511.
39. Potts R O, Francoeur M L. Lipid biophysics of water loss through the skin. Proc Natl Acad Sci USA 1990: 87: 3871-3873.
40. Feldmann R J, Maibach H I. Regional variation in percutaneous absorption of [14C] cortisol in man. J Invest Dermatol 1967: 48: 181-183.
41. Fisher A A. Allergic reaction to feminine hygiene sprays. Arch Dermatol 1973: 108: 801-802.
42. Lewis F M, Shah M, Gawkrodger D J. Contact sensitivity in pruritus vulvae: patch test results and clinical outcome. Am J Contact Dermat 1997: 8: 137-140.
43. Harris D, Robinson J R. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 1992: 81: 1-10.
44. Sayani A P, Chien Y W. Systemic delivery of peptides and proteins across absorptive mucosae. Crit Rev Ther Drug Carrier Syst 1996: 13: 85-184.
45. Squier C A. The permeability of oral mucosa. Crit Rev Oral Biol Med 1991: 2: 13-32.
46. Gorodeski G I. The cultured human cervical epithelium: a new model for studying paracellular transport. J Soc Gynecol Investig 1996: 3: 267-280.
47. Aungst B J. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci 1993: 82: 979-987.
48. Edwards J, Morris H. Langerhans' cells and lymphocyte subsets in the female genital tract. Br J Obstet Gynaecol 1985: 92: 974-982.
49. Young W. Epithelial kinetics affect Langerhans' cells of mouse vaginal epithelium. Acta Anat 1985: 123: 131-136.